Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zinc acetate - Eton Pharmaceuticals

Next Previous
Drug Profile

Zinc acetate - Eton Pharmaceuticals

Alternative Names: ET-700; Galzin; Wilzin; Zinc acetate dihydrate - Teva Pharmaceuticals

Latest Information Update: 02 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lemmon
  • Developer Eton Pharmaceuticals; Orphan Europe; Teva Pharmaceuticals USA
  • Class Acetates; Antiacnes; Antidiarrhoeals; Heavy metals
  • Mechanism of Action Chelating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hepatolenticular degeneration
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatolenticular degeneration

Most Recent Events

  • 20 Mar 2026 Eton Pharmaceuticals plans a proof-of-concept positron emission tomography (PET) study in April 2026
  • 20 Mar 2026 Eton Pharmaceuticals plans to initiate a dose-ranging and pivotal study in early 2027, contingent on the success of the proof-of-concept positron emission tomography (PET) study
  • 04 Apr 2025 As of December 2024, Eton Pharmaceuticals is scheduling a meeting with the US FDA in 2025 to discuss the clinical development plan

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top